Moderna Inc (MRNA) — Cash Flow-to-Debt Ratio
Moderna Inc (MRNA) has a Cash Flow-to-Debt Ratio of -0.15x as of March 2026, meaning its operating cash flow of $-630.00 Million could theoretically repay 0% of its total liabilities ($4.08 Billion) in one year. See how much free cash does Moderna Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Moderna Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Moderna Inc across 12 annual periods. Also explore net asset momentum of Moderna Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Moderna Inc (2014–2025)
Year-by-year debt coverage analysis for Moderna Inc. For market capitalisation and broader financial context, see Moderna Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.51x | $-1.87 Billion | $3.69 Billion | ▲ +45.2% |
| 2024 | -0.93x | $-3.00 Billion | $3.24 Billion | ▼ -35.9% |
| 2023 | -0.68x | $-3.12 Billion | $4.57 Billion | ▼ -192.2% |
| 2022 | 0.74x | $4.98 Billion | $6.74 Billion | ▼ -42.9% |
| 2021 | 1.29x | $13.62 Billion | $10.52 Billion | ▲ +204.9% |
| 2020 | 0.42x | $2.03 Billion | $4.78 Billion | ▲ +138.3% |
| 2019 | -1.11x | $-458.97 Million | $414.61 Million | ▼ -44.5% |
| 2018 | -0.77x | $-330.87 Million | $431.91 Million | ▼ -6.1% |
| 2017 | -0.72x | $-331.48 Million | $459.19 Million | ▼ -722.3% |
| 2016 | 0.12x | $66.73 Million | $575.31 Million | ▲ +102.7% |
| 2015 | -4.30x | $-738.15K | $171.66K | ▼ -1122.5% |
| 2014 | -0.35x | $-4.78 Million | $13.59 Million | — |